Literature DB >> 8766057

[Morphology of early retinal lesions after experimental venous occlusion].

C Kalogeropoulos1, G Donati, G P Pizzolato, C J Pournaras.   

Abstract

PURPOSE: Study of early hystological lesions after experimental branch venous occlusion (BVO) in miniature pigs.
MATERIALS AND METHODS: The retina was taken 1, 2, 4, 6 and 8 hours after BVO with green argon laser for examination with conventional and electronic microscopy.
RESULTS: 1 hour after occlusion an extracellular focal oedema is observable in the ganglion cells optic nerve fibers and cells of inner plexiform layer; 2 hours after occlusion there is also an extracellular oedema of the external plexiform layer as intracellular oedema of the inner nuclear layer, 4 hours after occlusion the extracellular oedema is more diffuse especially in the ganglion cells, inner nuclear and optic nerve fibers layers. Cytoplasmic vacuolisation, nuclear pycnosis and ruptured cell membrane layers are observed; 8 hours after occlusion both intra and extracellular oedema are observable throughout the inner retina.
CONCLUSIONS: After BVO histological lesions are found within one hour only following the occlusion, apoptosis and cell necrosis are present as soon as 4 hours after experimental BVO.

Entities:  

Mesh:

Year:  1996        PMID: 8766057     DOI: 10.1055/s-2008-1035245

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Bevacizumab in retinal vein occlusion-results of a prospective case series.

Authors:  Andreas Stahl; Hansjürgen Agostini; Lutz L Hansen; Nicolas Feltgen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-14       Impact factor: 3.117

2.  Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).

Authors:  Siamak Moradian; Hooshang Faghihi; Babak Sadeghi; Niloofar Piri; Hamid Ahmadieh; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina; Mohammad Riazi Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

3.  Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results.

Authors:  George J Manayath; V Narendran; Nadia Al-Kharousi; Upender K Wali
Journal:  Oman J Ophthalmol       Date:  2009-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.